Advertisement

Annals of Biomedical Engineering

, Volume 41, Issue 9, pp 1979–1989 | Cite as

Pulsatile Perfusion Bioreactor System for Durability Testing and Compliance Estimation of Tissue Engineered Vascular Grafts

  • Stefanos E. Diamantouros
  • Luis G. Hurtado-Aguilar
  • Thomas Schmitz-Rode
  • Petra Mela
  • Stefan JockenhoevelEmail author
Article

Abstract

The aim of the study was to design, construct, and test a bioreactor for the conditioning of tissue-engineered vascular grafts under physiological pressure, flow, and environmental conditions and up to supra-physiological pulse frequencies (5 Hz) as the first step towards durability testing. The system also allows the calculation of the compliance of vascular grafts as an indicator of tissue development. The system relies on the combination of a pulse-free pump and a linear magnetic actuator applying pressure pulses with controllable profile and frequency. The compliance estimation is based on the accurate measurement of the vessel’s diameter by means of an optical micrometre. Software-based interface enables the control of a magnetic actuator and data acquisition to monitor the conditions of the system. Porcine carotid arteries were tested in the bioreactor for up to 4 weeks at different pulse frequencies. The tissue was analysed by means of histology and immunohistochemistry. Physiological pressures (~80 and 120 mmHg for diastolic and systolic phase, respectively) were generated in the system at frequencies between 1 and 5 Hz. The environmental conditions within the bioreactor were monitored and online determination of the compliance of the arteries was achieved under sterile conditions. Conditioning of the grafts resulted in the abundant production of ECM proteins. In conclusion, we developed a bioreactor for the conditioning of tissue engineered vascular grafts under controlled pressure conditions. The system is suitable to perform durability tests at supra-physiological pulse rates and physiological pressure levels under continuous monitoring of environmental variables (pH, pO2, pCO2, and temperature) and compliance.

Keywords

Bioreactor Vascular graft Tissue engineering Compliance Mechanical conditioning 

Notes

Acknowledgments

This research was carried out in the framework of the Transregio 37 project “Mikro- und Nanosystheme in der Medizin – Rekonstruktion biologischer Funktionen” funded by the German Research Foundation.

References

  1. 1.
    Bilodeau, K., F. Couet, F. Boccafoschi, and D. Mantovani. Design of a perfusion bioreactor specific to the regeneration of vascular tissues under mechanical stresses. Artif. Organs 29:906–912, 2005.PubMedCrossRefGoogle Scholar
  2. 2.
    Bilodeau, K., and D. Mantovani. Bioreactors for tissue engineering: focus on mechanical constraints. A comparative review. Tissue Eng. 12:2367–2383, 2006.PubMedCrossRefGoogle Scholar
  3. 3.
    Bilodeau, K., and D. Mantovani. Bioreactors for tissue engineering: focus on mechanical constraints. A comparative review. Tissue Eng. 12(8):2367–2383, 2006.PubMedCrossRefGoogle Scholar
  4. 4.
    Campbel, E. M., P. A. Cahill, and C. Lally. Investigation of a small-diameter decellularised artery as a potential scaffold for vascular tissue engineering; biomechanical evaluation and preliminary cellseeding. J. Mech. Behav. Biomed. Mater. 14:130–142, 2012.CrossRefGoogle Scholar
  5. 5.
    Chamiot-Clerc, P., X. Copie, J. Renaud, M. Safar, and X. Girerd. Comparative reactivity and mechanical properties of human isolated internal mammary and radial arteries. Cardiovasc. Res. 37:811–819, 1998.PubMedCrossRefGoogle Scholar
  6. 6.
    Chen, H. C., and Y. C. Hu. Bioreactors for tissue engineering. Biotechnol. Lett. 28:1415–1423, 2006.PubMedCrossRefGoogle Scholar
  7. 7.
    Colombo, A., S. Guha, J. N. Mackle, P. A. Cahill, and C. Lally. Cyclic strain amplitude dictates the growth response of vascular smooth muscle cells in vitro: role in in-stent restenosis and inhibition with a sirolimus drug-eluting stent. Biomech. Model. Mechanobiol. 2012. doi: 10.1007/s10237-012-0433-4.
  8. 8.
    Despopoulos, A., and S. Silbernagl. Color Atlas of Physiology. Stuttgart: Georg Thieme Verlag, 2001.Google Scholar
  9. 9.
    El-Kurdi, M. S., J. S. Vipperman, and D. A. Vorp. Control of circumferential wall stress and luminal shear stress within intact vascular segments perfused ex vivo. J. Biomech. Eng. 130(5):051003, 2008.PubMedCrossRefGoogle Scholar
  10. 10.
    El-Kurdi, M. S., J. S. Vipperman, and D. A. Vorp. Design and subspace system identification of an ex vivo vascular perfusion system. J. Biomech. Eng. 131(4):041012, 2009.PubMedCrossRefGoogle Scholar
  11. 11.
    Engelmayr, Jr., G. C., E. Rabkin, F. W. Sutherland, F. J. Schoen, J. E. Mayer, Jr., and M. S. Sacks. The independent role of cyclic flexure in the early in vitro development of an engineered heart valve tissue. Biomaterials 26:175–187, 2005.PubMedCrossRefGoogle Scholar
  12. 12.
    Flanagan, T. C., J. S. Sachweh, J. Frese, et al. In vivo remodeling and structural characterization of fibrin-based tissue-engineered heart valves in the adult sheep model. Tissue Eng. 15(10):2965–2976, 2009.CrossRefGoogle Scholar
  13. 13.
    Food and Drug Administration, US Department of Health and Human Services. Draft Guidance for Industry and FDA Staff Heart Valves—Investigational Device Exemption (IDE) and Premarket Approval (PMA) Applications, Jan 20 2010.Google Scholar
  14. 14.
    Gilbert, T. W., A. M. Stewart-Akers, J. Sydeski, T. D. Nguyen, S. F. Badylak, and S. L. Woo. Gene expression by fibroblasts seeded on small intestinal submucosa and subjected to cyclic stretching. Tissue Eng. 13:1313–1323, 2007.PubMedCrossRefGoogle Scholar
  15. 15.
    Hahn, M. S., M. K. McHale, E. Wang, R. H. Schmedlen, and J. L. West. Physiological pulsatile flow bioreactor conditioning of poly(ethylene glycol)-based tissue engineered vascular grafts. Ann. Biomed. Eng. 35:190–200, 2007.PubMedCrossRefGoogle Scholar
  16. 16.
    Hoerstrup, S. P., I. Cummings, M. Lachat, et al. Functional growth in tissue-engineered living, vascular grafts: follow-up at 100 weeks in a large animal model. Circulation 114:I159–I166, 2006.PubMedCrossRefGoogle Scholar
  17. 17.
    Isenberg, B. C., C. Williams, and R. T. Tranquillo. Small-diameter artificial arteries engineered in vitro. Circ. Res. 98:25–35, 2006.PubMedCrossRefGoogle Scholar
  18. 18.
    Iwasaki, K., K. Kojima, S. Kodama, et al. Bioengineered three-layered robust and elastic artery using hemodynamically-equivalent pulsatile bioreactor. Circulation 118(14 Suppl):S52–S57, 2008.PubMedCrossRefGoogle Scholar
  19. 19.
    Jockenhoevel, S., G. Zund, S. P. Hoerstrup, A. Schnell, and M. Turina. Cardiovascular tissue engineering: a new laminar flow chamber for in vitro improvement of mechanical tissue properties. ASAIO J. 48:8–11, 2002.PubMedCrossRefGoogle Scholar
  20. 20.
    Joseph, J., and V. Jayashankar. A virtual instrument for real-time in vivo measurement of carotid artery compliance. In: 30th Annual International IEEE EMBS Conference 2008, Canada.Google Scholar
  21. 21.
    Koch, S., T. C. Flanagan, J. S. Sachweh, et al. Fibrin-polylactide-based tissue-engineered vascular graft in the arterial circulation. Biomaterials 31(17):4731–4739, 2010.PubMedCrossRefGoogle Scholar
  22. 22.
    Kortsmit, J., N. J. B. Driessen, M. C. M. Rutten, and F. P. T. Baaijens. Real time, non-invasive assessment of leaflet deformation in heart valve tissue engineering. Ann. Biomed. Eng. 37:532–541, 2009.PubMedCrossRefGoogle Scholar
  23. 23.
    Kreitz, S., G. Dohmen, S. Hasken, T. Schmitz-Rode, P. Mela, and S. Jockenhoevel. Nondestructive method to evaluate the collagen content of fibrin-based tissue engineered structures via ultrasound. Tissue Eng. C 17(10):1021–1026, 2011.CrossRefGoogle Scholar
  24. 24.
    Kurobe, H., M. W. Maxfield, C. K. Breuer, and T. Shinoka. Concise review: tissue-engineered vascular grafts for cardiac surgery: past, present and future. Stem Cells Transl. Med. 1:566–571, 2012.PubMedCrossRefGoogle Scholar
  25. 25.
    L’Heureux, N., N. Dusserre, G. Konig, et al. Human tissue engineered blood vessel for adult arterial revascularisation. Nat. Med. 12(3):361–365, 2006.PubMedCrossRefGoogle Scholar
  26. 26.
    Li, Z., S. Howarth, M. Graves, and J. H. Gillard. Measurement of stenotic carotid arterial compliance with MRI. In: 30th Annual International IEEE EMBS Conference 2008, Canada.Google Scholar
  27. 27.
    Long, A., L. Rouet, F. Vitry, et al. Compliance of abdominal aortic aneurysms before and after stenting with tissue Doppler imaging: evolution during follow-up and correlation with aneurysm diameter. Ann. Vasc. Surg. 23:49–59, 2009.PubMedCrossRefGoogle Scholar
  28. 28.
    Minister of Public Works and Government Services Canada. Draft Guidance for Industry—Pre-market Guidance on Bare Cardiovascular Stents, Apr 8 2004.Google Scholar
  29. 29.
    Mironov, V., V. Kasyanov, K. McAllister, S. Oliver, J. Sistino, and R. Markwald. Perfusion bioreactor for vascular tissue engineering with capacities for longitudinal stretch. J. Craniofac. Surg. 14:340–347, 2003.PubMedCrossRefGoogle Scholar
  30. 30.
    Narita, Y., K. Hata, H. Kagami, A. Usui, M. Ueda, and Y. Ueda. Novel pulse duplicating bioreactor system for tissue-engineered vascular construct. Tissue Eng. 10:1224–1233, 2004.PubMedGoogle Scholar
  31. 31.
    Niklason, L. E., J. Gao, W. M. Abbott, et al. Functional arteries grown in vitro. Science 284:489–493, 1999.PubMedCrossRefGoogle Scholar
  32. 32.
    Peck, M., D. Gebhart, N. Dusserre, T. N. McAllister, and N. L’Heureux. The evolution of vascular tissue engineering and current state of the art. Cells Tissues Organs 195:144–158, 2012.PubMedCrossRefGoogle Scholar
  33. 33.
    Poertner, R., S. Nagel-Heyer, C. Goepfert, P. Adamietz, and N. M. Meenen. Bioreactor design for tissue engineering. J. Biosci. Bioeng. 100:235–245, 2005.CrossRefGoogle Scholar
  34. 34.
    Rentschler, M. E., and B. T. Baxter. Screening aortic drug treatments through arterial compliance measurements. Curr. Vasc. Pharmacol. 6(4):250–257, 2008.PubMedCrossRefGoogle Scholar
  35. 35.
    Reutsch, P., H. Wagdy, R. Reusch, E. Wilson, and H. E. Ives. Mechanical strain increases smooth muscle and decreases nonmuscle expression in rat vascular smooth muscle cells. Circ. Res. 79:1046–1053, 1996.CrossRefGoogle Scholar
  36. 36.
    Ricea, M. A., K. R. Waters, and K. S. Anseth. Ultrasound monitoring of cartilaginous matrix evolution in degradable PEG hydrogels. Acta Biomater. 5(1):152–161, 2009.CrossRefGoogle Scholar
  37. 37.
    Shaikh, F. M., T. P. O’Brien, A. Callanan, et al. New pulsatile hydrostatic pressure bioreactor for vascular tissue-engineered constructs. Artif. Organs 34(2):153–158, 2010.PubMedCrossRefGoogle Scholar
  38. 38.
    Sheridan, W. S., G. P. Duffy, and B. P. Murphy. Mechanical characterization of a customized decellularized scaffold for vascular tissue engineering. J. Mech. Behav. Biomed. Mater. 8:58–70, 2012.PubMedCrossRefGoogle Scholar
  39. 39.
    Syedain, Z. H., L. A. Meier, J. W. Bjork, A. Lee, and R. T. Tranquillo. Implantable arterial grafts from human fibroblasts and fibrin using a multi-graft pulsed flow-stretch bioreactor with noninvasive strength monitoring. Biomaterials 32:714–722, 2011.PubMedCrossRefGoogle Scholar
  40. 40.
    Test Methods for Vascular Prostheses: Determination of Dynamic Compliance. Geneva, Switzerland, ISO 7198:1998 (E).Google Scholar
  41. 41.
    Toussaint, N. D., K. K. Lau, B. J. Strauss, K. R. Polkinghorne, and P. G. Kerr. Relationship between vascular calcification, arterial stiffness and bone mineral density in a cross-sectional study of prevalent Australian haemodialysis patients. Nephrology (Carlton) 14(1):105–112, 2009.CrossRefGoogle Scholar
  42. 42.
    Trächslin, J., M. Koch, and M. Chiquet. Rapid and reversible regulation of collagen XII expression by changes in tensile stress. Exp. Cell Res. 247:320–328, 1999.PubMedCrossRefGoogle Scholar
  43. 43.
    Tschoeke, B., T. C. Flanagan, S. Jockenhoevel, et al. Development of a composite degradable/non-degradable tissue-engineered vascular graft. Artif. Organs 33(2):194–196, 2009.PubMedGoogle Scholar
  44. 44.
    Vismara, R., M. Soncini, G. Talo, et al. A bioreactor with compliance monitoring for heart valve grafts. Ann. Biomed. Eng. 38:100–108, 2010.PubMedCrossRefGoogle Scholar
  45. 45.
    Williams, C., and T. M. Wick. Perfusion bioreactor for small diameter tissue-engineered arteries. Tissue Eng. 10:930–941, 2004.PubMedCrossRefGoogle Scholar
  46. 46.
    World Health Organisation. Estimated total deaths, by cause and WHO Member State, 2002, http://www.who.int/research/en/, accessed on 15 December 2010.
  47. 47.
    Wright, G. Mechanical stimulation of cardiac function by means of pulsatile blood pumps. J. Cardiothorac. Vasc. Anesth. 11(3):299–309, 1997.PubMedCrossRefGoogle Scholar
  48. 48.
    Yazdani, S. K., and J. L. Berry. Development of an in vitro system to assess stent-induced smooth muscle cell proliferation: a feasibility study. J. Vasc. Interv. Radiol. 20(1):101–106, 2009.PubMedCrossRefGoogle Scholar

Copyright information

© Biomedical Engineering Society 2013

Authors and Affiliations

  • Stefanos E. Diamantouros
    • 1
  • Luis G. Hurtado-Aguilar
    • 1
  • Thomas Schmitz-Rode
    • 1
  • Petra Mela
    • 1
  • Stefan Jockenhoevel
    • 1
    Email author
  1. 1.Department of Tissue Engineering & Textile Implants, AME-Helmholtz Institute for Biomedical EngineeringAachen UniversityAachenGermany

Personalised recommendations